Design of RESILIENCE: A phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer Meeting Abstract
| Authors: | Baselga, J.; Costa, F.; Gomez, H.; Hudis, C.; Rapoport, B.; Roche, H.; Schwartzberg, L. S.; Petrenciuc, O.; Shan, M.; Gradishar, W. J. |
| Abstract Title: | Design of RESILIENCE: A phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer |
| Meeting Title: | 9th Conference on Madrid Breast Cancer |
| Journal Title: | Breast Cancer Research |
| Volume: | 13 |
| Issue: | Suppl.2 |
| Meeting Dates: | 2011 Nov 16-17 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 1465-5411 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2011-01-01 |
| Start Page: | S5 |
| Language: | English |
| DOI: | 10.1186/bcr3011 |
| ACCESSION: | WOS:000303915000013 |
| PROVIDER: | wos |
| PMCID: | PMC3247045 |
| Notes: | --- - Meeting Abstract: O12 - 9th Conference on Madrid Breast Cancer - NOV 16-17, 2011 - Madrid, SPAIN - "2" - - "Source: Wos" |
